Glyphic Biotechnologies
company
About
Next generation protein sequencing.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $409.29K
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$409.29K
Glyphic Biotechnologies has raised a total of
$409.29K
in funding over 2 rounds. Their latest funding was raised on
Sep 2, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 2, 2022 | Grant | $409.29K | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Glyphic Biotechnologies is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
